/Investor DB

Apollo Health Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Tubulis GmbHtubulis.comin𝕏Series A · Jul 2020 · $12Macquired by Gilead Sciences

Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics.

BiotechDeep TechMedical DevicesPlanegg-Martinsried, DE

Dominik Schumacher(Co-founder & CEO)inJonas Helma-Smets(Co-founder & Chief Scientific Officer)Christian Hackenberger(Scientific Co-founder)

Co-investorsAndera PartnersBioMedPartnersEQT Life SciencesNexTech VenturesAscenta CapitalBayern Kapital+7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.